dgn-np:NP57252.RAPEfAUR-3nJ0B4-qslsnpIT4WKQHWpTOwBQ3TsGopWZU130_provenance {
  dgn-np:NP57252.RAPEfAUR-3nJ0B4-qslsnpIT4WKQHWpTOwBQ3TsGopWZU130_assertion dcterms:description "[This study is the first to investigate a relationship between 5HT2A/2C receptor polymorphisms, serum olanzapine concentrations, and clinical response, and supports a potential relationship between serotonin receptor polymorphisms and negative symptom response in schizophrenia. These results have important implications for the inclusion of genetic factors in clinical schizophrenia research. Due to the relatively small sample size and relatively brief olanzapine response and polymorphisms of the 5HT2A/2C receptor alleles need to be replicated in a larger sample.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ;
    wi:evidence dgn-void:source_evidence_literature ;
    sio:SIO_000772 miriam-pubmed:12454564 ;
    prov:wasDerivedFrom dgn-void:gad-20130706 ;
    prov:wasGeneratedBy eco:ECO_0000203 .
  dgn-void:gad-20130706 pav:importedOn "2013-07-06"^^xsd:date .
  dgn-void:source_evidence_literature a eco:ECO_0000212 ;
    rdfs:comment "Gene-disease associations inferred from text-mining the literature."@en ;
    rdfs:label "DisGeNET evidence - LITERATURE"@en .
}